Press release 2022-06-28
ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.
Video 2022-06-21
Redeye - Get to know Ola Winqvist
Press release 2022-06-20
Delegation from Bangladesh visits ISR for study preparation
News 2022-06-07
Redeye Growth Day June 2nd
Press release 2022-06-02
Kommuniké från årsstämma i ISR Immune System Regulation Holding AB (publ) den 2 juni 2022
Preklinisk studie visar att ISR-052 ger långsiktigt skydd mot SARS-CoV-2
Press release 2022-05-20
ISR tecknar avtal med Gerresheimer för omfattande produktion av IcoOne näsinhalatorer för kliniskt bruk.
Press release 2022-05-10
ISR – Immune System Regulation Holding AB (publ) har stärkt sin kortsiktiga finansiering
News 2022-05-05
Redeye initiating coverage
Press release 2022-05-03
ISR Immune System Regulation Holding AB (publ) kallar till årsstämma
© ISR Immune System Regulation Holding AB (publ). All rights reserved.
Retzius väg 11
SE-171 65 Solna, Sweden
Email: info@israb.se
Phone: +46 705 42 79 39